COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 1941: Articles 19401-19410  | Next

Rapid SARS-CoV-2 Detection and Classification Using Phase Imaging with Computational Specificity
Goswami, N., He, Y. R., Deng, Y.-H., Oh, C., Sobh, N., Valera, E., Bashir, R., Ismail, N., Kong, H. J., Nguyen, T. H., Best-Popescu, C., Popescu, G.
10.1101/2020.12.14.422601 — Posted: 2020-12-15
Using Mobility Data to Understand and Forecast COVID19 Dynamics
Wang, L., Ben, X., Adiga, A., Sadilek, A., Tendulkar, A., Venkatramanan, S., Vullikanti, A., Aggarwal, G., Talekar, A., Chen, J., Lewis, B. L., Swarup, S., Kapoor, A., Tambe, M., Marathe, M.
10.1101/2020.12.13.20248129 — Posted: 2020-12-15
Evolution of COVID-19 patients treated with a combination of nutraceuticals to reduce symptomatology and improve prognosis: a multi-centred, retrospective cohort study
Hernandez, M., Urrea, J., Bascoy, L.
10.1101/2020.12.11.20246561 — Posted: 2020-12-15
Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial
Ella, R., Mohan, K., Jogdand, H., Prasad, S., Reddy, S., Sarangi, V. K., Ganneru, B., Sapkal, G., Yadav, P., Panda, S., Gupta, N., Reddy, P., Verma, S., Rai, S., Singh, C., Redkar, S., Gillurkar, C. S., Kushwaha, J. S., Rao, V., Mohapatra, S., Guleria, R., Ella, K., Bhargava, B.
10.1101/2020.12.11.20210419 — Posted: 2020-12-15
Foistar(Camostat mesylate) associated with the significant decrease in CRP levels compared to Kaletra(Lopinavir/Ritonavir) treatment in Korean mild COVID-19 pneumonic patients.
Choi, J.-P., Choi, J.-P., Kim, H.-J., Han, J., Park, S., Han, J.
10.1101/2020.12.10.20240689 — Posted: 2020-12-15
Does Contact Tracing Work? Quasi-Experimental Evidence from an Excel Error in England
Fetzer, T., Graeber, T.
10.1101/2020.12.10.20247080 — Posted: 2020-12-15
Decomposing the sources of SARS-CoV-2 fitness variation in the United States
Kepler, L., Hamins-Puertolas, M., Rasmussen, D. A.
10.1101/2020.12.14.422739 — Posted: 2020-12-14
Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70
Kemp, S., Datir, R., Collier, D., Ferreira, I., Carabelii, A., Harvey, W., Robertson, D. L., Gupta, R. K.
10.1101/2020.12.14.422555 — Posted: 2020-12-14 Discussion: Onsite | Offsite
SARS-CoV-2 Requires Cholesterol for Viral Entry and Pathological Syncytia Formation
Sanders, D. W., Jumper, C. C., Ackerman, P. J., Bracha, D., Donlic, A., Kim, H., Kenney, D., Castello-Serrano, I., Suzuki, S., Tamura, T., Tavares, A. H., Saeed, M., Holehouse, A. S., Ploss, A., Levental, I., Douam, F., Padera, R. F., Levy, B. D., Brangwynne, C. P.
10.1101/2020.12.14.422737 — Posted: 2020-12-14
Targeting Scavenger Receptor Type B-1 (SR-B1) and Cholesterol Inhibits Entry of SARS-CoV-2 Pseudovirus in Cell Culture
Henrich, S. E., McMahon, K. M., Palacio, N., Bhalla, P., Penaloza-MacMaster, P., Thaxton, C. S.
10.1101/2020.12.14.420133 — Posted: 2020-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).